Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « supportive »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
supporting < supportive < supports  Facettes :

List of bibliographic references indexed by supportive

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000075 (2021) Sawsan Elgohary [Égypte] ; Aya A. Elkhodiry [Égypte] ; Nada S. Amin [Égypte] ; Ulrike Stein [Allemagne] ; Hend M. El Tayebi [Égypte]Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
000105 (2021) Nour K. Younis [Liban] ; Rana O. Zareef [Liban] ; Mohammad Ali N. Maktabi [Liban] ; Rami Mahfouz [Liban]The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
000125 (2021) Andy Sing Ong Tang ; Tze Shin Leong ; Lee Ping Chew ; Hock Hin ChuaSuccessful Non-surgical Treatment of an Acute Calculous Cholecystitis in a Myeloma Patient with Covid-19: Case Report.
000132 (2021) Kanupriya Arora [Inde] ; Prasan Kumar Panda [Oman]Steroid harms if given early in COVID-19 viraemia.
000294 (2021) Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde]One year update on the COVID-19 pandemic: Where are we now?
000358 (2021) Hassan Askari [Iran] ; Nima Sanadgol [Iran, Brésil] ; Asaad Azarnezhad [Iran] ; Amir Tajbakhsh [Iran] ; Hossein Rafiei [Canada] ; Ali Reza Safarpour [Iran] ; Seyed Mohammad Gheibihayat [Iran] ; Ehsan Raeis-Abdollahi [Iran] ; Amir Savardashtaki [Iran] ; Ali Ghanbariasad [Iran] ; Navid Omidifar [Iran]Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives.
000436 (2021) Rajnish Kumar [Inde] ; Anju Sharma [Inde] ; Janmejai Kumar Srivastava [Inde] ; Mohammed Haris Siddiqui [Inde] ; Md Sahab Uddin [Bangladesh] ; Lotfi Aleya [France]Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications.
000492 (2021) Reshma Golamari [États-Unis] ; Neeru Kapoor [Inde] ; Tanuja Devaraj [États-Unis] ; Nitasa Sahu [États-Unis] ; Courtney Kramer [États-Unis] ; Rohit Jain [États-Unis]Experimental therapies under investigation for COVID-19.
000514 (2021) Maria Gavriatopoulou [Grèce] ; Ioannis Ntanasis-Stathopoulos [Grèce] ; Eleni Korompoki [Grèce, Royaume-Uni] ; Despina Fotiou [Grèce] ; Magdalini Migkou [Grèce] ; Ioannis-Georgios Tzanninis [Royaume-Uni] ; Theodora Psaltopoulou [Grèce] ; Efstathios Kastritis [Grèce] ; Evangelos Terpos [Grèce] ; Meletios A. Dimopoulos [Grèce]Emerging treatment strategies for COVID-19 infection.
000532 (2021) Shadma Wahab ; Md Faruque Ahmad ; Arshad Hussain ; Shazia Usmani ; Ambreen Shoaib ; Wasim AhmadEffectiveness of Azithromycin as add-on Therapy in COVID-19 Management.
000589 (2021) Matthew P. Fox ; Lucy D'Agostino Mcgowan ; Bryan D. James ; Justin Lessler ; Shruti H. Mehta ; Eleanor J. MurrayConcerns About the Special Article on Hydroxychloroquine and Azithromycin in High-Risk Outpatients With COVID-19.
000668 (2021) Saad I. Mallah [Oman] ; Omar K. Ghorab ; Sabrina Al-Salmi ; Omar S. Abdellatif [Canada] ; Tharmegan Tharmaratnam [Irlande (pays)] ; Mina Amin Iskandar ; Jessica Atef Nassef Sefen ; Pardeep Sidhu ; Bassam Atallah [Émirats arabes unis, États-Unis] ; Rania El-Lababidi [Émirats arabes unis] ; Manaf Al-Qahtani [Oman]COVID-19: breaking down a global health crisis.
000725 (2021) Shuqian Chen [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Junping Wen [République populaire de Chine] ; Baosong Xie [République populaire de Chine] ; Lizhou Chen [République populaire de Chine] ; Gang Chen [République populaire de Chine]Are glucagon-like peptide 1 analogues effective and safe in severe COVID-19 patients with type 2 diabetes?—a case report
000768 (2021) Maheswara Rao Gokada ; Visweswara Rao Pasupuleti ; Hari Babu BollikollaA mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19.
000777 (2021) Theerachai Thammathiwat [Thaïlande] ; Somkanya Tungsanga [Thaïlande] ; Kanitha Tiankanon [Thaïlande] ; Pattama Torvorapanit [Thaïlande] ; Worawat Chumpangern [Thaïlande] ; Suwasin Udomkarnjananun [Thaïlande] ; Yingyos Avihingsanon [Thaïlande] ; Thitiwat Sriprasart [Thaïlande] ; Nattachai Srisawat [Thaïlande] ; Kamonwan Jutivorakool [Thaïlande] ; Leilani Paitoonpong [Thaïlande] ; Opass Putcharoen [Thaïlande] ; Natavudh Townamchai [Thaïlande]A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post-kidney transplant recipient.
000997 (2020) Zeinab Imani-Saber [Iran] ; Hajar Vaseghi [Iran] ; Mojdeh Mahdian [Iran] ; Fatemeh Safari [Iran] ; Mohsen Ghadami [Iran]Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
000A91 (2020) Rishita Pujari [États-Unis] ; Mary V. Thommana [États-Unis] ; Brisandi Ruiz Mercedes [États-Unis] ; Ayna Serwat [États-Unis]Therapeutic Options for COVID-19: A Review.
000B18 (2020) Pan Zhai [République populaire de Chine] ; Yanbing Ding [République populaire de Chine] ; Xia Wu [République populaire de Chine] ; Junke Long [République populaire de Chine] ; Yanjun Zhong [République populaire de Chine] ; Yiming Li [République populaire de Chine]The epidemiology, diagnosis and treatment of COVID-19.
000C46 (2020) Nadia Castaldo [Italie] ; Alberto Aimo [Italie] ; Vincenzo Castiglione [Italie] ; Cristiano Padalino [Italie] ; Michele Emdin [Italie] ; Carlo Tascini [Italie]Safety and Efficacy of Amiodarone in a Patient With COVID-19.
000E83 (2020) Muhammad S. Mian ; Laiba Razaq ; Safeera Khan [États-Unis] ; Nadia Hussain ; Mahrukh RazaqPathological Findings and Management of COVID-19 Patients: A Brief Overview of Modern-day Pandemic.
000E95 (2020) Sapna A. Mehta [États-Unis] ; Jeanette Leonard [États-Unis] ; Pauline Labella [États-Unis] ; Katarzyna Cartiera [États-Unis] ; Irfana Soomro [États-Unis] ; Henry Neumann [États-Unis] ; Robert A. Montgomery [États-Unis] ; Nicole M. Ali [États-Unis]Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "supportive" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "supportive" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    supportive
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021